QQQ   291.14 (-4.91%)
AAPL   140.82 (-5.64%)
MSFT   254.08 (-4.77%)
FB   192.24 (-5.12%)
GOOGL   2,237.99 (-3.93%)
AMZN   2,142.25 (-7.16%)
TSLA   709.81 (-6.80%)
NVDA   169.38 (-6.82%)
BABA   87.31 (-5.09%)
NIO   15.83 (-4.81%)
AMD   96.28 (-6.04%)
CGC   5.59 (-5.09%)
MU   71.05 (-4.61%)
T   20.23 (-1.65%)
GE   75.20 (-1.57%)
F   12.78 (-5.54%)
DIS   104.30 (-3.99%)
AMC   12.76 (-1.09%)
PFE   50.40 (-1.83%)
PYPL   77.18 (-3.22%)
NFLX   177.19 (-7.02%)
QQQ   291.14 (-4.91%)
AAPL   140.82 (-5.64%)
MSFT   254.08 (-4.77%)
FB   192.24 (-5.12%)
GOOGL   2,237.99 (-3.93%)
AMZN   2,142.25 (-7.16%)
TSLA   709.81 (-6.80%)
NVDA   169.38 (-6.82%)
BABA   87.31 (-5.09%)
NIO   15.83 (-4.81%)
AMD   96.28 (-6.04%)
CGC   5.59 (-5.09%)
MU   71.05 (-4.61%)
T   20.23 (-1.65%)
GE   75.20 (-1.57%)
F   12.78 (-5.54%)
DIS   104.30 (-3.99%)
AMC   12.76 (-1.09%)
PFE   50.40 (-1.83%)
PYPL   77.18 (-3.22%)
NFLX   177.19 (-7.02%)
QQQ   291.14 (-4.91%)
AAPL   140.82 (-5.64%)
MSFT   254.08 (-4.77%)
FB   192.24 (-5.12%)
GOOGL   2,237.99 (-3.93%)
AMZN   2,142.25 (-7.16%)
TSLA   709.81 (-6.80%)
NVDA   169.38 (-6.82%)
BABA   87.31 (-5.09%)
NIO   15.83 (-4.81%)
AMD   96.28 (-6.04%)
CGC   5.59 (-5.09%)
MU   71.05 (-4.61%)
T   20.23 (-1.65%)
GE   75.20 (-1.57%)
F   12.78 (-5.54%)
DIS   104.30 (-3.99%)
AMC   12.76 (-1.09%)
PFE   50.40 (-1.83%)
PYPL   77.18 (-3.22%)
NFLX   177.19 (-7.02%)
QQQ   291.14 (-4.91%)
AAPL   140.82 (-5.64%)
MSFT   254.08 (-4.77%)
FB   192.24 (-5.12%)
GOOGL   2,237.99 (-3.93%)
AMZN   2,142.25 (-7.16%)
TSLA   709.81 (-6.80%)
NVDA   169.38 (-6.82%)
BABA   87.31 (-5.09%)
NIO   15.83 (-4.81%)
AMD   96.28 (-6.04%)
CGC   5.59 (-5.09%)
MU   71.05 (-4.61%)
T   20.23 (-1.65%)
GE   75.20 (-1.57%)
F   12.78 (-5.54%)
DIS   104.30 (-3.99%)
AMC   12.76 (-1.09%)
PFE   50.40 (-1.83%)
PYPL   77.18 (-3.22%)
NFLX   177.19 (-7.02%)
OTCMKTS:DIGP

Digipath (DIGP) Stock Forecast, Price & News

$0.02
+0.00 (+5.56%)
(As of 05/18/2022 03:32 PM ET)
Add
Compare
Today's Range
$0.02
▼
$0.02
50-Day Range
$0.01
▼
$0.03
52-Week Range
$0.01
▼
$0.09
Volume
13,060 shs
Average Volume
166,478 shs
Market Capitalization
$1.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.15
View Price History Chart DataSkip Price History Chart
30 days | 90 days | 365 days | Advanced Chart
Receive DIGP News and Ratings via Email

Sign-up to receive the latest news and ratings for Digipath and its competitors with MarketBeat's FREE daily newsletter.

Digipath logo

About Digipath

Digipath, Inc., together with its subsidiaries, provides cannabis and hemp lab testing services in Las Vegas to Nevada licensed medical marijuana enterprises. It also provides testing, cannabis education and training, and cannabis news coverage to the cannabis industry. The company operates as a testing laboratory facility for cannabis, cannabis infused products, hemp, and other botanical nutraceuticals to serve growers, dispensaries, caregivers, producers, patients, and end users of cannabis and botanical products. In addition, its labs screen medicinal and recreational cannabis for potentially harmful contaminants, including residual solvents; moisture; water activity; visual inspection; pesticides; heavy metals, such as mercury, arsenic, lead, cadmium, chromium, and nickel; biological toxins comprising aflatoxin and ocratoxins; and microbial contaminants consisting of E. coli, salmonella, coliforms, aspergillus, gram negative bacteria, total aerobic bacteria, and mold and yeast. Digipath, Inc. was incorporated in 2010 and is headquartered in Las Vegas, Nevada.

Headlines

May 2, 2022 | finance.yahoo.com
Digipath Validates and Receives Approval to Use Free DNA Removal to Test for Aspergillus
April 4, 2022 | msn.com
Digipath To Test Redwood Cultivation Products, Including Mike Tyson's Ear Shaped Cannabis Gummies
April 4, 2022 | seekingalpha.com
Digipath to provide product testing for Redwood Cultivation Products
April 4, 2022 | finance.yahoo.com
Digipath to Provide Product Testing for Redwood Cultivation Products, Including Mike Tyson’s New Ear Shaped Gummies, ‘Mike Bites’
March 1, 2022 | benzinga.com
Digipath Teams Up With CASPR Technologies To Determine Efficacy For New Anti-Microbial Product For Cannabis Industry
March 1, 2022 | finance.yahoo.com
Digipath Enters Into Validation Agreement with CASPR Technologies to Determine Efficacy for New Anti-Microbial Product for the Cannabis Industry
February 15, 2022 | msn.com
Digipath Reports Substantial Sequential Growth In Gross Profit & Revenue In Q1
February 15, 2022 | finance.yahoo.com
Digipath Announces Financial Results for Q1, 2022
February 9, 2022 | finance.yahoo.com
Digipath Obtains Coveted Compliance Testing License for California Laboratory
January 4, 2022 | finance.yahoo.com
Digipath Announces Results for the Fiscal Year 2021
December 7, 2021 | finance.yahoo.com
EVIO Inc. Executes Letter of Intent to sell C3 Labs, LLC to Digipath, Inc.
December 7, 2021 | finance.yahoo.com
Digipath Takes Over Management & Signs Letter of Intent to Acquire Majority Control of Steep Hill’s Licensed Northern California Lab from Evio Labs
December 6, 2021 | finance.yahoo.com
Digipath, Inc. to Present at the Emerging Growth Conference on Wednesday, December 8th at 12n EST/ 9:00 am PST
See More Headlines

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Management consulting services
Sub-Industry
Cannabis
Sector
Medical
Current Symbol
OTCMKTS:DIGP
Previous Symbol
CUSIP
N/A
CIK
1502966
Web
www.digipath.com
Phone
(702) 527-2060
Fax
N/A
Employees
17
Year Founded
N/A

Sales & Book Value

Annual Sales
$2.50 million
Price / Sales
0.57
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.01) per share
Price / Book
-1.90

Profitability

EPS (Most Recent Fiscal Year)
N/A
Net Income
$-690 thousand
Net Margins
-21.68%
Pretax Margin
-21.68%
Return on Equity
N/A
Return on Assets
-33.14%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.46
Quick Ratio
0.46

Price-To-Earnings

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A

Miscellaneous

Outstanding Shares
75,147,000
Free Float
67,031,000
Market Cap
$1.43 million
Optionable
Not Optionable

Company Calendar

Last Earnings
8/13/2019
Today
5/18/2022
Fiscal Year End
9/30/2022

MarketRank™

Overall MarketRank™

1.05 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -













Digipath (OTCMKTS:DIGP) Frequently Asked Questions

How were Digipath's earnings last quarter?

Digipath, Inc. (OTCMKTS:DIGP) released its quarterly earnings results on Tuesday, August, 13th. The company reported ($0.01) earnings per share (EPS) for the quarter. The firm earned $0.65 million during the quarter.
View Digipath's earnings history.

Who are Digipath's key executives?
Digipath's management team includes the following people:
  • Mr. Todd Denkin, Founder & Pres (Age 58, Pay $198k)
  • Mr. A. Stone Douglass, Chairman, CFO & Sec. (Age 74)
  • Dr. Drazen M. Jukic M.D., Ph.D., Exec. Officer
  • Mr. Bo Deitl, Consultant
What other stocks do shareholders of Digipath own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Digipath investors own include Freedom Leaf (FRLF), AT&T (T), BP (BP), GrowGeneration (GRWG), KushCo (KSHB), Lumen Technologies (LUMN), AdvisorShares Pure US Cannabis ETF (MSOS), Rocky Mountain High Brands (RMHB), Unrivaled Brands (TRTC) and Agritek (AGTK).

What is Digipath's stock symbol?

Digipath trades on the OTCMKTS under the ticker symbol "DIGP."

How do I buy shares of Digipath?

Shares of DIGP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Digipath's stock price today?

One share of DIGP stock can currently be purchased for approximately $0.02.

How much money does Digipath make?

Digipath has a market capitalization of $1.43 million and generates $2.50 million in revenue each year.

How many employees does Digipath have?

Digipath employs 17 workers across the globe.

What is Digipath's official website?

The official website for Digipath is www.digipath.com.

How can I contact Digipath?

Digipath's mailing address is 6450 CAMERON STREET SUITE 113, LAS VEGAS NV, 89118. The company can be reached via phone at (702) 527-2060 or via email at [email protected].

This page was last updated on 5/18/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.